Patents by Inventor Robert McKinnell

Robert McKinnell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diaryl ether beta2 adrenergic receptor agonists
    Publication number: 20080113981
    Abstract: The invention provides novel ?2 adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with ?2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: November 19, 2007
    Publication date: May 15, 2008
    Inventors: Robert McKinnell, Edmund Moran
  • Crystalline form of a benzimidazole-carboxamide medicinal compound
    Publication number: 20060270854
    Abstract: The invention provides crystalline forms of the novel benzimidazole-carboxamide 5-HT4 receptor agonist compound, 4-(4-{[(2-isopropyl-1H-benzoimidazole-4-carbonyl)amino]methyl}-piperidin-1-ylmethyl)piperidine-1-carboxylic acid methyl ester. The invention also provides pharmaceutical compositions comprising the crystalline compound, methods of using the compound to treat diseases associated with 5-HT4 receptor activity, and processes useful for preparing crystalline forms of the compound.
    Type: Application
    Filed: May 24, 2006
    Publication date: November 30, 2006
    Inventors: Sean Dalziel, Kirsten Phizackerley, Robert McKinnell, Roland Gendron, Seok-ki Choi, Daniel Long
  • Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists
    Publication number: 20060270652
    Abstract: The invention relates to benzimidazole-carboxamide 5-HT4 receptor agonist compounds of formula (I) wherein R1 and X are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: May 24, 2006
    Publication date: November 30, 2006
    Inventors: Robert McKinnell, Roland Gendron, Lan Jiang, Seok-ki Choi, Daniel Long, Paul Fatheree, Daniel Marquess
  • Diaryl ether beta2 adrenergic receptor agonists
    Publication number: 20060019991
    Abstract: The invention provides novel ?2 adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with ?2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: July 20, 2005
    Publication date: January 26, 2006
    Applicant: Theravance, Inc.
    Inventors: Robert McKinnell, Edmund Moran
  • Aryl aniline derivatives as beta2 adrenergic receptor agonists
    Publication number: 20050159448
    Abstract: The invention provides novel ?2 adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with ?2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: January 11, 2005
    Publication date: July 21, 2005
    Inventors: Robert McKinnell, John Jacobsen, Sean Trapp, Daisuke Saito